Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
March 7, 2009
Gene modification in embryonic stem cells by single-stranded DNA oligonucleotides
Marieke Aarts, Marleen Dekker, Rob Dekker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2016
Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants
Hellen Houlleberghs, Marleen Dekker, Hildo Lantermans, et al.
Journal of Medical Genetics
|
December 1, 2019
Three-step site-directed mutagenesis screen identifies pathogenic <i>MLH1</i> variants associated with Lynch syndrome
Hellen Houlleberghs, Marleen Dekker, Jarnick Lusseveld, et al.
International Journal for Equity in Health
|
August 30, 2019
Leaving no one behind? Social inclusion of health insurance in low- and middle-income countries: a systematic review
Suzanne G M van Hees, Timothy O'Fallon, Miranda Hofker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2016
LNA modification of single-stranded DNA oligonucleotides allows subtle gene modification in mismatch-repair-proficient cells
Thomas W van Ravesteyn, Marleen Dekker, Alexander Fish, et al.
Mutation Research
|
August 2, 2011
Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides
Marleen Dekker, Sandra de Vries, Marieke Aarts, et al.
Elife
|
October 17, 2018
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells
Bente Benedict, Tanja van Harn, Marleen Dekker, et al.
Gastroenterology
|
August 5, 2014
Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome
Kamila Wojciechowicz, Erika Cantelli, Bastiaan Van Gerwen, et al.
Plos Genetics
|
May 23, 2017
Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity
Hellen Houlleberghs, Anne Goverde, Jarnick Lusseveld, et al.
Cancer Research
|
July 25, 2014
RB family tumor suppressor activity may not relate to active silencing of E2F target genes
Tinke L Vormer, Kamila Wojciechowicz, Marleen Dekker, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Methods in Molecular Biology (Clifton, N.J.)
|
March 7, 2009
Gene modification in embryonic stem cells by single-stranded DNA oligonucleotides
Marieke Aarts, Marleen Dekker, Rob Dekker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2016
Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants
Hellen Houlleberghs, Marleen Dekker, Hildo Lantermans, et al.
Journal of Medical Genetics
|
December 1, 2019
Three-step site-directed mutagenesis screen identifies pathogenic <i>MLH1</i> variants associated with Lynch syndrome
Hellen Houlleberghs, Marleen Dekker, Jarnick Lusseveld, et al.
International Journal for Equity in Health
|
August 30, 2019
Leaving no one behind? Social inclusion of health insurance in low- and middle-income countries: a systematic review
Suzanne G M van Hees, Timothy O'Fallon, Miranda Hofker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2016
LNA modification of single-stranded DNA oligonucleotides allows subtle gene modification in mismatch-repair-proficient cells
Thomas W van Ravesteyn, Marleen Dekker, Alexander Fish, et al.
Mutation Research
|
August 2, 2011
Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides
Marleen Dekker, Sandra de Vries, Marieke Aarts, et al.
Elife
|
October 17, 2018
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells
Bente Benedict, Tanja van Harn, Marleen Dekker, et al.
Gastroenterology
|
August 5, 2014
Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome
Kamila Wojciechowicz, Erika Cantelli, Bastiaan Van Gerwen, et al.
Plos Genetics
|
May 23, 2017
Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity
Hellen Houlleberghs, Anne Goverde, Jarnick Lusseveld, et al.
Cancer Research
|
July 25, 2014
RB family tumor suppressor activity may not relate to active silencing of E2F target genes
Tinke L Vormer, Kamila Wojciechowicz, Marleen Dekker, et al.
Page
of 3